Associate Director, CDx Partnership Program ManagementActive$209K

The opportunity

Location: Hybrid in San Carlos, CA preferred but US Remote is considered

What you'll do

  • Serve as a senior Program Management lead and trusted advisor for: pharmaceutical CDx partnerships, bringing deep experience and judgment from managing a broad portfolio of complex CDx collaborations.

  • Partner with Business Development to evaluate new CDx opportunities before: deal execution, assessing feasibility, scope, timelines, resource requirements, risks, and cost to ensure proposed partnerships are operationally viable

  • Serve as a senior external-facing Program Management contact for: pharmaceutical partners, building strong relationships and leading effective program governance and strategic discussions.

  • Translate partner strategy, priorities, expectations, and commitments into: clear direction and context for internal CDx Program Managers and cross-functional teams.

  • Maintain a portfolio-level view across multiple pharma partnerships and CDx: programs, identifying cross-program risks, resource needs, financial implications, and opportunities for improved planning.

  • Partner closely with CDx Program Managers who own detailed development: planning and execution, ensuring alignment between external commitments and internal delivery.

What they're looking for

  • Identify and escalate gaps between partner expectations, contractual scope,: budget, timelines, and development realities before they impact the partnership or program.
  • Help establish scalable frameworks, governance models, and best practices to: support continued growth of the CDx pharma partnership portfolio.
  • Extensive, hands-on experience across a substantial portfolio of CDx: pharmaceutical partnerships, ideally with 10+ CDx deals/programs successfully advanced from deal evaluation through execution and delivery.
  • Deep understanding of the CDx/IVD development lifecycle and the activities,: timelines, regulatory considerations, resources, and costs required to develop and deliver a companion diagnostic.